Deal Announcements

BrainCells Nets $30 Million Second Financing

Tuesday, March 11, 2008 5:46:00 AM PDT | VentureDeal Staff

SAN DIEGO, CA -- BrainCells, Inc. announced the completion of the initial closing of its series B round of venture capital, receiving $30 million.

The company is developing drugs for depression, related neuropsychiatric disorders and other central nervous system diseases.

Investors in the round included MedImmune which led the financing, Bay City Capital, Oxford Bioscience Partners, Technology Partners, Pappas Ventures and others.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1